Grifols SA
OTC:GIFLF

Watchlist Manager
Grifols SA Logo
Grifols SA
OTC:GIFLF
Watchlist
Price: 13.9 USD -0.71%
Market Cap: $9.4B

Profitability Summary

Grifols SA's profitability score is 48/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

48/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

48/100
Profitability
Score
48/100
Profitability
Score

Margins

Earnings Waterfall
Grifols SA

Margins Comparison
Grifols SA Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
ES
Grifols SA
MAD:GRF
7.4B EUR
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
389.3B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.3B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
170.5B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.2B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.1B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
42.4B EUR
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.4B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Grifols SA Competitors

Country Company Market Cap ROE ROA ROCE ROIC
ES
Grifols SA
MAD:GRF
7.4B EUR
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
389.3B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.3B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
170.5B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.2B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.1B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
42.4B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.4B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Grifols SA

Last Value
3-Years Average
FCF Margin
Conversion Rate